Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island
Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island
Organogenesis宣佈計劃通過與位於羅德島史密斯菲爾德的100科技大道的生物製造設施簽訂長期租約來擴展製造業-半導體的產能。
Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.
Organogenesis控股公司（納斯達克：ORGO），一家領先的再生醫學公司，專注於開發、製造和商業化在Advanced Wound Care和手術及體育醫學市場產品解決方案，宣佈計劃通過租賃長期租約，擴大在羅德島史密斯菲爾德市100 Technology Way的122,000平方英尺最先進的生物製造設施的製造能力。
熱門討論
中概股財報季火熱：驚喜盈利能否延續漲勢？
1. 哪些行業可能成為本輪財報季的市場焦點？ 2. 在政府強調科技創新和可持續發展的背景下，你認為哪些行業具有最大的增長潜力？
Moomoo News Global
03/04 23:26
中國兩會：會議前後股票價格變動的關鍵要點